Shonukan, O, AH Dantzig, S Kloeker-Rhoades, and I Garcia-Ribas. “Development of LY2334737, an Oral Gemcitabine Prodrug for Continuous Administration. Perspectives for the Therapy of Mature T-Cell and NK-Cell Lymphomas”. Hematology Meeting Reports (formerly Haematologica Reports) 3, no. 1 (June 11, 2009). Accessed July 22, 2024. https://www.pagepress.org/journals/hmr/article/view/533.